| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.79B | 3.20B | 2.99B | 3.08B | 2.72B |
| Gross Profit | 662.30M | 985.50M | 1.10B | 875.90M | 794.20M |
| EBITDA | 921.50M | 1.77B | 334.80M | 1.84B | 1.68B |
| Net Income | -246.70M | -128.50M | -93.50M | -300.00K | 11.10M |
Balance Sheet | |||||
| Total Assets | 5.24B | 5.12B | 5.10B | 4.41B | 4.33B |
| Cash, Cash Equivalents and Short-Term Investments | 182.40M | 205.70M | 277.00M | 210.90M | 256.90M |
| Total Debt | 159.00M | 3.66B | 3.72B | 3.18B | 2.76B |
| Total Liabilities | 6.38B | 6.04B | 6.13B | 4.85B | 4.26B |
| Stockholders Equity | -1.28B | -1.05B | -1.15B | -780.40M | -261.30M |
Cash Flow | |||||
| Free Cash Flow | -78.90M | -120.30M | 479.00M | 339.60M | -441.10M |
| Operating Cash Flow | -65.60M | -106.80M | 488.90M | 346.10M | -435.00M |
| Investing Cash Flow | -11.40M | -35.40M | -331.80M | 31.30M | -180.70M |
| Financing Cash Flow | -13.50M | 84.50M | -74.90M | -394.50M | 525.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $387.68B | 36.11 | 43.25% | ― | 15.49% | 35.54% | |
68 Neutral | $176.28B | 21.11 | 11.35% | 1.10% | 3.61% | 152.34% | |
68 Neutral | $23.33B | 34.54 | 16.22% | 0.75% | 14.91% | 9.30% | |
62 Neutral | $68.00B | 98.11 | 2.05% | ― | -4.29% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $10.17B | -1.44 | -4.36% | 1.48% | -0.48% | 97.09% | |
51 Neutral | $2.68B | -14.33 | 20.86% | ― | 97.19% | -21.46% |
On March 17, 2026, Lionsgate Studios Corp. held its Annual General and Special Meeting of Shareholders, where 90.92% of common shares entitled to vote were represented in person or by proxy, reflecting strong shareholder engagement. At the meeting, investors approved all board nominees, reappointed Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending March 31, 2026, and backed the advisory vote on executive compensation, signaling broad support for current governance, oversight, and pay practices.
The director slate, including figures such as Gordon Crawford, Jon Feltheimer, Steven Mnuchin, and others, received approval rates largely above 80%, with Mnuchin drawing 99.78% of votes cast in favor, underscoring confidence in the board’s composition. The 99.63% support for Ernst & Young LLP and an 80.19% favorable vote on executive compensation suggest continuity in financial oversight and leadership strategy, which may provide operational stability and reassure investors about the company’s governance framework.
The most recent analyst rating on (LION) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on Lionsgate Studios stock, see the LION Stock Forecast page.
On January 26, 2026, Lionsgate Studios entered into a governance, standstill and voting agreement with Liberty 77-affiliated funds and MHR Fund Management that installs Liberty Strategic Capital’s managing partner and former U.S. Treasury Secretary Steven T. Mnuchin as a Liberty-designated independent director on its board, bringing the total number of directors to eleven. Under the deal, Liberty 77 and MHR have agreed to mutual voting support for each other’s board nominees and to refrain from activist measures such as increasing their stakes above 17.5%, launching proxy contests or other actions that could challenge Lionsgate’s governance structure for a defined multi-year period, while receiving pre-emptive, registration and “most favored nation” rights aligned with existing major shareholders; the company does not anticipate Mnuchin’s appointment will materially alter its operations but expects his financial, regulatory and entertainment experience, as well as the alignment with significant shareholders, to reinforce board oversight and governance stability for investors.
The most recent analyst rating on (LION) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Lionsgate Studios stock, see the LION Stock Forecast page.
Lionsgate Studios Corp. has scheduled its initial annual general and special meeting of shareholders for March 17, 2026, to be held at its Canadian head office, with further details to be provided in a forthcoming proxy statement. The company has established January 20, 2026, as the deadline for shareholder proposals to be included in the proxy materials under Rule 14a-8, and February 13, 2026, as the cutoff for eligible shareholders to submit director nominations, reinforcing formal governance processes and providing a clear timetable for investor participation in corporate decision-making.
The most recent analyst rating on (LION) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on Lionsgate Studios stock, see the LION Stock Forecast page.